Navigation Links
Rigel to Present at Two Upcoming Investor Conferences
Date:8/25/2011

SOUTH SAN FRANCISCO, Calif., Aug. 25, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, chairman and chief executive officer, and Ryan Maynard, executive vice president and chief financial officer of Rigel, will present at two separate investor conferences in September. Details of the events are as follows:Stifel Nicolaus Healthcare Conference 2011Date: Thursday, September 8th at 10:20 a.m. ETLocation: Boston, MASpeaker: James M GowerUBS Global Life Sciences ConferenceDate: Tuesday, September 20th at 1:30 p.m. ETLocation: New York, NYSpeaker: Ryan MaynardBoth presentations will be webcast.  To access the live audio webcast or subsequent archived recording, log on to www.rigel.com.  Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its Phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that has completed Phase 1 trials for asthma.

Contact: Ryan Maynard
Phone: 650.624.1284
Email: invrel@rigel.com


'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Rigel to Present at Wells Fargo Securities Healthcare Conference
2. Rigel to Present at Jefferies Global Healthcare Conference
3. Rigel Announces Pricing of Public Offering of Common Stock
4. Rigel Announces Proposed Public Offering of Common Stock
5. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
6. Rigel Announces First Quarter Financial Results
7. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
8. Rigel to Present at Three Upcoming Investor Conferences
9. Rigel Announces Participation at Two Investor Conferences
10. Rigel to Present at JP Morgan Healthcare Conference
11. Rigel Announces Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... -- Giving people with low vision hope – and choices ... Academy of Low Vision Specialists (IALVS), whose member ... forefront of low vision care. The academy works to ... treatment options available to patients who present with low ... Recently, doctors in six new states and ...
(Date:6/3/2015)... -- PARI Respiratory Equipment has won a 2015 American Package Design ... the FDA on December 2, is the first co-packaging of ... Nebulizer for patients with cystic fibrosis. ... this unique product offering of nebulized drug and device.  In ... we also wanted to convey that the components suit each ...
(Date:6/3/2015)... , June 3, 2015  OncoSec Medical Inc. ... DNA-based intratumoral cancer immunotherapies, today announced that it ... institutional investors to purchase approximately $13.6 million of ... agreed to sell to such investors an aggregate ... a price of $5.50 per share. ...
Breaking Medicine Technology:International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 3International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 4Kitabis Pak Wins American Package Design Award 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 3
... WALTHAM, Mass., Sept. 14, 2010 Amylin Pharmaceuticals, Inc. ... (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ... research findings on BYETTA® (exenatide) injection and the investigational ... presented at the 46th Annual Meeting of the European ...
... Sept. 14 Reportlinker.com announces that a ... its catalogue: Healthcare IT ... Hospital Information Systems and Medical Imaging Information ... Healthcare IT Market Outlook ...
Cached Medicine Technology:BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010 2BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010 3BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010 4BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010 5BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010 6BYETTA® and BYDUREON™ to be Featured in More Than a Dozen Study Presentations at EASD 2010 7Reportlinker Adds Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems 2Reportlinker Adds Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems 3Reportlinker Adds Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems 4Reportlinker Adds Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems 5Reportlinker Adds Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems 6Reportlinker Adds Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems 7Reportlinker Adds Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems 8
(Date:6/3/2015)... 03, 2015 Follow us on ... has revolutionized disease treatment on account of their better ... diseases, such as rheumatoid arthritis. The industry is expected ... traditional small molecule drugs to biopharmaceuticals over the coming ... cell and gene therapies, and recombinant proteins has attracted ...
(Date:6/3/2015)... On June 22, 2015, Medicare will ... sensitivity (pharmacogenetic) testing that it has reimbursed since 2009. ... 19 million of the 49 million Medicare beneficiaries in the ... adverse drug events.(1) Sadly, if it became a standard of ... the use of an individual’s genetic information to tailor treatment, ...
(Date:6/3/2015)... On the heels of a report predicting bioinformatics ... click here to review news coverage about the report ... has the talent to become a world-leading center of the ... biological data are collected and analyzed to help scientists discover ... elements of a perfect storm for bioinformatics leadership,” said Dr. ...
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Dr. Steven ... York Cardiac Diagnostic Center ( http://www.newyorkcardiac.com ) located in NYC, ... on weekdays to his practice. In most cases, depending on ... of the day they call, they will be seen by ... first priority as a cardiologist is to ensure that people ...
Breaking Medicine News(10 mins):Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2
... study published in the Lancet, researchers had suggested that ... HPV virus might vary from country to country all ... developed against two types of virus that cause cervical ... high-risk HPV infections in Europe than sub-Saharan Africa. ...
... with the new biologic drug adalimumab and methotrexate has ... for people with long-standing rheumatoid arthritis when compared to ... been found to decrease pain and swelling in patients ... ,At the end of the 6-month trial, 43 percent ...
... could be happier than the poor taking into consideration factors ... ,The study was conducted on a group of people ... were questioned regarding their age, total family income and general ... older, race and marital status. ,The analysis of ...
... the state administration of Maharastra who have been under ... floods are now under defensive and are controlling the ... health authorities have reported fewer admissions of new ... such as leptospirosis and dengue showed signs of abating. ...
... men with early stage prostate cancer who make drastic changes ... reverse the progression of their illness say researchers//. The study ... that lifestyle changes may affect the progression of a cancer. ... in men after lung cancer. For the study researchers recruited ...
... latest BMJ said that results of a randomized controlled ... help pregnant smokers quit or cut down had yielded ... mothers//. ,A third of pregnant women smoke and ... support to help them quit. Motivational interviewing - a ...
Cached Medicine News:Health News:Trained Counselors Counseling Pregnant Smokers To Quit May Not Work 2
... The Smith & Nephew ECTRA II ... release the carpal tunnel ligament endoscopically, allowing ... proximal cutting, while minimizing endoscopic lens fogging ... the surgeon complete visualization and control. ECTRA ...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
... Cross-Screw System offers the surgeon ... for ACL reconstruction utilizing soft ... System provides the latest technology ... comes in Titanium as well ...
Medicine Products: